Blood pressure and expression of microRNAs in whole blood

Background Blood pressure (BP) is a complex, multifactorial clinical outcome driven by genetic susceptibility, behavioral choices, and environmental factors. Many molecular mechanisms have been proposed for the pathophysiology of high BP even as its prevalence continues to grow worldwide, increasing morbidity and marking it as a major public health concern. To address this, we evaluated miRNA profiling in blood leukocytes as potential biomarkers of BP and BP-related risk factors. Methods The Beijing Truck Driver Air Pollution Study included 60 truck drivers and 60 office workers examined in 2008. On two days separated by 1–2 weeks, we examined three BP measures: systolic, diastolic, and mean arterial pressure measured at both pre- and post-work exams for blood NanoString nCounter miRNA profiles. We used covariate-adjusted linear mixed-effect models to examine associations between BP and increased miRNA expression in both pooled and risk factor-stratified analyses. Results Overall 43 miRNAs were associated with pre-work BP (FDR<0.05). In stratified analyses different but overlapping groups of miRNAs were associated with pre-work BP in truck drivers, high-BMI participants, and usual alcohol drinkers (FDR<0.05). Only four miRNAs were associated with post-work BP (FDR<0.05), in ever smokers. Conclusion Our results suggest that many miRNAs were significantly associated with BP in subgroups exposed to known hypertension risk factors. These findings shed light on the underlying molecular mechanisms of BP, and may assist with the development of a miRNA panel for early detection of hypertension.

[1]  J. Schwartz,et al.  Particulate Air Pollution Exposure and Expression of Viral and Human MicroRNAs in Blood: The Beijing Truck Driver Air Pollution Study , 2015, Environmental health perspectives.

[2]  K. Kario.  Morning Surge in Blood Pressure and Cardiovascular Risk: Evidence and Perspectives , 2010, Hypertension.

[3]  J. Raj,et al.  MicroRNAs in pulmonary arterial hypertension. , 2015, American journal of respiratory cell and molecular biology.

[4]  W. Elliott,et al.  Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1. Blood Pressure Measurement in Humans. A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure ResearchPickering , 2006 .

[5]  J. Staessen,et al.  Prognosis in relation to blood pressure variability: con side of the argument. , 2015, Hypertension.

[6]  S. Rubin,et al.  Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). , 2003, The American journal of cardiology.

[7]  C. Henríquez-Roldán,et al.  Systemic inflammation, endothelial dysfunction, and activation in clinically healthy children exposed to air pollutants. , 2008, Inhalation toxicology.

[8]  A Pedotti,et al.  Blood Pressure and Heart Rate Variabilities in Normotensive and Hypertensive Human Beings , 1983, Circulation research.

[9]  J. Schwartz,et al.  Altered methylation in tandem repeat element and elemental component levels in inhalable air particles , 2014, Environmental and molecular mutagenesis.

[10]  R. Hayes,et al.  Concordance with DASH diet and blood pressure change: results from the Framingham Offspring Study (1991–2008) , 2015, Journal of hypertension.

[11]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[12]  Walter W. Holland.  Risk factors for high blood pressure , 1982 .

[13]  E. Raftery,et al.  CIRCADIAN VARIATION OF BLOOD-PRESSURE , 1978, The Lancet.

[14]  N. Morrell,et al.  A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension. , 2015, American journal of respiratory and critical care medicine.

[15]  Yanjie Lu,et al.  Downregulation of miR-151-5p Contributes to Increased Susceptibility to Arrhythmogenesis during Myocardial Infarction with Estrogen Deprivation , 2013, PloS one.

[16]  L. Hou,et al.  Characterization of genome-wide H3K27ac profiles reveals a distinct PM2.5-associated histone modification signature , 2015, Environmental Health.

[17]  J. Schwartz,et al.  Effects of particulate matter exposure on blood 5-hydroxymethylation: results from the Beijing truck driver air pollution study , 2015, Epigenetics.

[18]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[19]  J. Schwartz,et al.  Inhalable particulate matter and mitochondrial DNA copy number in highly exposed individuals in Beijing, China: a repeated-measure study , 2013, Particle and Fibre Toxicology.

[20]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[21]  J. Chen,et al.  Global Gene Expression Profiling in Whole-Blood Samples from Individuals Exposed to Metal Fumes , 2004, Environmental health perspectives.

[22]  F. J. Ensell,et al.  ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.

[23]  Thomas Sandström,et al.  Health effects of acute exposure to air pollution. Part I: Healthy and asthmatic subjects exposed to diesel exhaust. , 2003, Research report.

[24]  Junjie Xiao,et al.  Circulating microRNAs: novel biomarkers for cardiovascular diseases , 2011, Journal of Molecular Medicine.

[25]  R. N. Haldar,et al.  Global Brief on Hypertension: Silent Killer, Global Public Health Crisis , 2013 .

[26]  J. Schwartz,et al.  Traffic‐derived particulate matter exposure and histone H3 modification: A repeated measures study , 2017, Environmental research.

[27]  I. Kallikazaros,et al.  Epigenetics, the missing link in hypertension. , 2015, Life sciences.

[28]  T. Fernandes,et al.  Exercise training in hypertension: Role of microRNAs. , 2014, World journal of cardiology.

[29]  C. Spradley,et al.  Circulating miRNAs as Potential Marker for Pulmonary Hypertension , 2013, PloS one.

[30]  Richard M. Millis,et al.  Epigenetics and Hypertension , 2011, Current hypertension reports.

[31]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[32]  N. Schork,et al.  MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. , 2013, Human molecular genetics.

[33]  Jie He,et al.  Histone Methylation in Nickel-Smelting Industrial Workers , 2015, PloS one.

[34]  V. Burt,et al.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. , 2013, NCHS data brief.

[35]  Joel Schwartz,et al.  Diabetes, Obesity, and Hypertension May Enhance Associations between Air Pollution and Markers of Systemic Inflammation , 2006, Environmental health perspectives.

[36]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[37]  G. Condorelli,et al.  Circulating MicroRNAs and Aerobic Fitness – The HUNT-Study , 2013, PloS one.

[38]  W. Xie,et al.  Characterization of the microRNA pool and the factors affecting its regulatory potential. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[39]  E. Olson,et al.  A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. , 2009, Developmental cell.

[40]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[41]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[42]  Tara M. Holmes,et al.  Atrial natriuretic peptide is negatively regulated by microRNA-425. , 2013, The Journal of clinical investigation.

[43]  W. Kuebler,et al.  The MicroRNA-130/301 Family Controls Vasoconstriction in Pulmonary Hypertension* , 2014, The Journal of Biological Chemistry.

[44]  F. Jiang,et al.  Circulating microRNAs Serve as Novel Biological Markers for Intracranial Aneurysms , 2014, Journal of the American Heart Association.

[45]  J. Schwartz,et al.  Effects of particulate air pollution on blood pressure in a highly exposed population in Beijing, China: a repeated-measure study , 2011, Environmental health : a global access science source.

[46]  Andrea Baccarelli,et al.  Epigenetics and environmental chemicals , 2009, Current opinion in pediatrics.

[47]  K. Kario.  Prognosis in relation to blood pressure variability: pro side of the argument. , 2015, Hypertension.

[48]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[49]  G. Gibson,et al.  Omic personality: implications of stable transcript and methylation profiles for personalized medicine , 2015, Genome Medicine.

[50]  Wen Wang,et al.  Summary of report on cardiovascular diseases in China, 2012. , 2014, Biomedical and environmental sciences : BES.

[51]  B. Yan,et al.  Dietary counselling has no effect on cardiovascular risk factors among Chinese Grade 1 hypertensive patients: a randomized controlled trial. , 2015, European heart journal.